SCHEMBL1398056

SCHEMBL1398056

COc1cccc2c1CN(C1CC(=O)NC1=O)C=N2

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.37
ACHE P22303 1/20 0.36
CRBN Q96SW2 5/20 0.36
DDB1 Q16531 4/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
PKM P14618 2/20 0.36
AADAT Q8N5Z0 1/20 0.35
PRKCA P17252 1/20 0.35
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
TSHR P16473 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
IKZF3 Q9UKT9 1/20 0.34
CDK5 Q00535 1/20 0.34
CDK5R1 Q15078 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1398045 0.88 CRBN (0.45) CREBBPCRBNDDB1ALDH1A1HTR2A
SCHEMBL1398130 0.88 TP53 (0.39) CREBBPCRBNDDB1POLBHTR2A
SCHEMBL1398091 0.87 TIPARP (0.38) CRBNDDB1POLBIKZF3
SCHEMBL1398048 0.84 CRBN (0.39) CREBBPACHECRBNDDB1ALDH1A1
SCHEMBL1398064 0.84 NPC1 (0.38) CRBNDDB1POLBHTR2AHTR2C
SCHEMBL1398095 0.84 CRBN (0.52) CREBBPCRBNDDB1IKZF3
SCHEMBL1398034 0.82 CRBN (0.35) CRBNDDB1ALDH1A1TSHRIKZF3
SCHEMBL1398032 0.82 CRBN (0.44) CRBNDDB1ALDH1A1TSHRIKZF3
SCHEMBL1398069 0.82 CRBN (0.39) CRBNDDB1ALDH1A1AADATTSHR
SCHEMBL1398075 0.82 LMNA (0.44) CRBNDDB1ALDH1A1TSHRIKZF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957481-B1 PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION GRUENENTHAL GMBH (DE) 2011-03-02 EP claimed
US-20080293749-A1 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position GRUENENTHAL GMBH (DE) 2008-11-27 US claimed
EP-1957481-B1 PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION GRUENENTHAL GMBH (DE) 2011-03-02 EP disclosed
US-20080293749-A1 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position GRUENENTHAL GMBH (DE) 2008-11-27 US disclosed
EP-1957481-A1 PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION Grünenthal GmbH (DE) 2008-08-20 EP disclosed
WO-2007062817-A1 PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION Grünenthal GmbH (DE) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293749-A1 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position TPMT, MALT1, THPO CREBBP 488/4885ACHE 4464/4885CRBN 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.